Abstract:The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) is a crucial innate defence mechanism against viral infection in the innate immune system, as it principally induces the production of type I interferons. Immune responses and metabolic control are inextricably linked, and chronic low-grade inflammation promotes the development of metabolic diseases. The cGAS-STING pathway activated by double-stranded DNA (dsDNA), cyclic dinucleotides (CDNs), endoplasmic reticulum stress (ER stress), mitochondrial stress, and energy imbalance in metabolic cells and immune cells triggers proinflammatory responses and metabolic disorders. Abnormal overactivation of the pathway is closely associated with metabolic diseases such as obesity, nonalcoholic fatty liver disease (NAFLD), insulin resistance and cardiovascular diseases (CVDs). The interaction of cGAS-STING with other pathways, such as the nuclear factor-kappa B (NF-κB), Jun N-terminal kinase (JNK), AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), autophagy, pyroptosis and insulin signalling pathways, is considered an important mechanism by which cGAS-STING regulates inflammation and metabolism. This review focuses on the link between immune responses related to the cGAS-STING pathway and metabolic diseases and cGAS-STING interaction with other pathways for mediating signal input and affecting output. Moreover, potential inhibitors of the cGAS-STING pathway and therapeutic prospects against metabolic diseases are discussed. This review provides a comprehensive perspective on the involvement of STING in immune-related metabolic diseases.

The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

cGAS-STING signaling in cardiovascular diseases

Role and Mechanism of cGAS-STING Pathway in Cardiovascular System

The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy

Lysosomal Control of the Cgas-Sting Signaling.

Cellular functions of cGAS-STING signaling

Cardiovascular diseases crossroads: cGAS-STING signaling and disease progression

Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases

Cgas/sting: Novel Perspectives of the Classic Pathway

Link between sterile inflammation and cardiovascular diseases: Focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect

The role of the cGAS-STING pathway in metabolic diseases

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases

The Cgas-Sting Pathway: Post-translational Modifications and Functional Implications in Diseases

Significance of the cGAS-STING Pathway in Health and Disease

Advances in cGAS-STING Signaling Pathway and Diseases

The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases

Cgas–sting, an Important Signaling Pathway in Diseases and Their Therapy

Trafficking and effect of released DNA on cGAS-STING signaling pathway and cardiovascular disease

Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response

The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention